Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bayer_AG
|
| gptkbp:acquisitionYear |
2006
|
| gptkbp:ceased_operations |
2006
|
| gptkbp:country |
gptkb:Germany
|
| gptkbp:founded |
1851
|
| gptkbp:founder |
gptkb:Ernst_Christian_Friedrich_Schering
|
| gptkbp:headquarters_location |
gptkb:Berlin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schering AG
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:logo |
Schering AG logo.svg
|
| gptkbp:main_research_focus |
oncology
diagnostic imaging multiple sclerosis gynecology |
| gptkbp:notableProduct |
gptkb:Androcur
gptkb:Primovist gptkb:Betaferon gptkb:Yasmin |
| gptkbp:numberOfEmployees |
approximately 26,000 (2005)
|
| gptkbp:parent_organization_(post-2006) |
gptkb:Bayer_AG
|
| gptkbp:stockExchange |
gptkb:Frankfurt_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:SCH
|
| gptkbp:successor |
gptkb:Bayer_Schering_Pharma
|
| gptkbp:website |
www.schering.de
|
| gptkbp:bfsParent |
gptkb:levonorgestrel
gptkb:Bayer_HealthCare gptkb:Jenapharm |
| gptkbp:bfsLayer |
6
|